This page lists all the Podcasts that are available from ASHP Advantage. To subscribe to ASHP Advantage Podcasts, and automatically receive new programs when they are published, copy the URL from the box below and paste it into your favorite podcasting tool (e.g., iTunes, iPodder). The program materials (e.g., slides, CE instructions, and post test) are also available via this page.
How to Subscribe?
Click on the icon below to subscribe directly using your preferred podcasting tool:
Or, copy and paste this URL into a podcasting tool.
Learn More About Podcasts
These podcasts include recordings of programs originally presented in a live setting, as well as interviews with faculty and other pharmacy leaders about important therapeutic and practice issues. The advantage of the podcast format is that you automatically receive the audio from the program in a format that can be listened to from your computer and transferred to a portable MP3 player. You do not need an iPod or MP3 player to take advantage of podcast convenience, audio files can be played on any computer with the ability to play audio files (i.e., Windows Media Player or other software).
Summary:
This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants.
Part 1 Highlighting One Patient's Story: The Impact of VTE
Michael P. Gulseth, Pharm.D., BCPS
(23 minutes)
Part 2 Development of a VTE Risk Assessment Model and Protocol
Jordan C. Messler, M.D., FHM
(21 minutes)
Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Learning Center.
Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout, which is available for download below.
This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Summary:
Multidisciplinary teams are vital for improving quality using a systems approach in the prevention of hospital-acquired VTE. This activity will outline a multidisciplinary team approach using practical strategies to improve the quality of VTE prophylaxis. Evidence-based guidelines for the safety and monitoring of anticoagulants in VTE prevention will be reviewed. An interactive format will be used to engage the participant in important VTE prevention team decisions.
Part 1 A Team Approach to Quality Improvement in VTE Prophylaxis
Jordan C. Messler, M.D., FHM
(23 minutes)
Part 2 Using Evidence-based Guidelines to Manage Anticoagulants in VTE Prophylaxis
Michael P. Gulseth, Pharm.D., BCPS
(21 minutes)
Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Learning Center.
Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout, which is available for download below.
This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.
Summary: Pharmacy Technicians' roles in the pharmacy continue to change as the responsibilities of pharmacists expand. Working under the supervision of the pharmacist, technicians are now performing duties that allow the pharmacist greater flexibility for direct patient care and implementation of new programs. This activity will highlight innovative practices for pharmacy technicians that advance the entire pharmacy team, and outline the benefits of Pharmacy Technician Certification Board (PTCB) certification in seeking these career paths.
Part 1 Innovative Pharmacy Technician Roles in Action
Rowell Daniels, Pharm.D., M.S.
(30 minutes)
Part 2 Case Study: A Tech-Check-Tech Pilot Study in an Academic Medical Center
Beth S. Williams, Pharm.D., BCPS
(30 minutes)
Part 3 Trained, Tested, and Trusted: PTCB Update
Miriam A. Mobley Smith, B.S.Pharm., Pharm.D.
(30 minutes)
Continuing Education The activity was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until August 31, 2011, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit. The ACPE activity number for pharmacists is 204-000-09-201-H01P and the ACPE activity number for technicians is 204-000-09-201-H01T.
Credits: This activity provides 2 hours (0.2 CEUs) of continuing education credit
This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).
CE in the Mornings from the 44th ASHP Midyear Clinical Meeting
Summary: Antimicrobial resistance in hospitals leads to increased morbidity, mortality, hospital lengths of stay, and healthcare costs and is now a major public health crisis. Implementing an antimicrobial stewardship program in a health system can present a challenge. Working with a multidisciplinary team to implement antimicrobial stewardship is recommended in clinical practice guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical pharmacists with infectious diseases training can play key roles in this effort.
This knowledge-based educational activity will outline the relationships between inappropriate antimicrobial use, antimicrobial resistance, and increased morbidity, mortality, hospital length of stay, and healthcare costs. The potential impact of antimicrobial stewardship programs on the emergence and transmission of antimicrobial-resistant microorganisms also will be discussed. Challenges associated with the implementation of antimicrobial stewardship programs and examples of successful multidisciplinary approaches to antimicrobial stewardship will be explained. The financial impact of recent Centers for Medicare and Medicaid Services (CMS) reimbursement policies for infectious disease-related never events, the implications for pharmacy practice of these policies, and the role of evidence-based strategies in preventing never events and antimicrobial resistance also will be addressed. The audience will be engaged in active learning strategies throughout the presentation.
Faculty: Debra A. Goff, Pharm.D., FCCP
Continuing Education The program was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until February 28, 2011. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. ACPE activity #204-000-09-442-H01P
Credits: 1 hour (0.1 CEU) of continuing pharmacy education credit
Summary Type 2 diabetes is the most common form of diabetes in the United States and is associated with significant long-term morbidity and mortality. Patients with diabetes are at much higher risk for development of both microvascular and macrovascular complications, including peripheral neuropathy, nephropathy, ophthalmic abnormalities, and cardiovascular disease. An estimated three out of five people with type 2 diabetes have at least one serious health problem associated with the disease. In 2008, the estimated direct and indirect costs of diabetes and its complications in the United States totaled nearly $215 billion.
Managing patients with type 2 diabetes is dependent on an in-depth understanding of currently available therapies (monotherapy and combination therapy), side effects, drug interactions, and monitoring parameters. Risks associated with co-morbid conditions, including cardiovascular disease and obesity, must be considered when formulating an appropriate treatment plan. Pharmacists engaged in diabetes care, such as providing self-management education, responding to patient questions, recommending lifestyle changes, encouraging patients to refill prescriptions and monitor blood glucose levels, and reviewing medications, have demonstrated significant improvements in glycemic control. Diabetes education programs accredited by the American Association of Diabetes Educators (AADE) are available for pharmacists to develop competencies in diabetes care. In March 2009, AADE became an approved Medicare provider for diabetes self-management training.
This educational activity will provide an overview of recent trends in the prevalence of type 2 diabetes and barriers to optimal therapy. The benefits of advancing therapy for patients who do not reach goal A1C < 7.0% will be discussed. The role of American Diabetes Association-recommended goals for A1C, blood pressure, and serum cholesterol, patient-specific variables and co-morbidities, and new therapeutic options will be considered. A best practices model for a pharmacy-based diabetes management program will be presented. Audience participation will be incorporated to illustrate important concepts and decision-making processes.
Part I: Current Concepts in the Pathogenesis and Approach to Treating Type 2 Diabetes
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Part 2:Improving Glycemic Control in Type 2 Diabetes: A Case-Study Approach
Curtis L. Triplitt, Pharm.D., CDE
Part 3: Best Practices in Diabetes Education: Strategies for Medication Adherence and Reimbursement
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Continuing Education The program was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, December of 2009. Continuing education for this podcast is available until February 28, 2011. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. ACPE activity #204-000-09-441-H01P
Credits: 1 hour (0.1 CEU) of continuing pharmacy education credit
Summary The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) recognizes the need for evidence-based policies to improve the delivery and receipt of immunization services recommended for adults. Important developments in preventable disease research and immunization products are frequent, making it a challenge for health-system pharmacists to stay current. ACIP recently issued updated recommendations for the prevention of meningococcal disease, measles-mumps-rubella 'evidence of immunity' requirements for healthcare personnel, and the use of pneumococcal vaccine. Pharmacists should be advised of ongoing research to address the prevention of these and other diseases, such as influenza A (H1N1) virus infection, that have the potential to have widespread adverse effects on public health.
Health-system pharmacists can provide education and vital leadership in the development of institution- or physician-approved protocols aimed at improving vaccination rates among adult patients and employees. A multidisciplinary team approach can lead to a successful standing order program (SOP). SOPs can be used effectively in a variety of institutional settings-inpatient and outpatient facilities, long-term care facilities, managed care organizations, assisted living facilities, correctional facilities, pharmacies, and home healthcare agencies-to vaccinate patients, residents, and employees.
This educational activity will provide an overview of the prevalence, morbidity, and mortality associated with vaccine-preventable diseases in adults. Recent changes to the ACIP recommendations for immunization and information about the efficacy, safety, and administration of new immunization products also will be discussed. Finally, the role of the pharmacist in the development of a health-system adult immunization program will be addressed.
Faculty: Michael D. Hogue, Pharm.D., FAPhA
Continuing Education The program was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, December of 2009. Continuing education for this podcast is available until February 28, 2011. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. ACPE activity #204-000-09-440-H01P
Credits: 1 hour (0.1 CEU) of continuing pharmacy education credit
Summary
It is estimated that 80 million adults in the United States, or approximately one in three, have one or more forms of cardiovascular (CV) disease. Efforts to reduce risks of morbidity and mortality associated with cardiovascular disease include managing hypertension and dyslipidemia, using antiplatelet agents appropriately, implementing lifestyle modifications, and promoting smoking cessation.
Multiple clinical trials on the management of dyslipidemia have demonstrated a significant reduction in CV morbidity and mortality with aggressive LDL cholesterol lowering in secondary prevention patients (those with established CHD). The results of these trials have led to a global acceptance of intensive dyslipidemia management in secondary prevention patients. However, preventing a first occurrence of CHD (primary prevention) remains an essential public health initiative. Moreover, recent evidence from the JUPITER trial and meta-analyses have redirected attention toward primary prevention.
The National Cholesterol Education Program (NCEP) Adult Treatment Panel, which is sponsored by the National Heart, Lung, and Blood Institute, is expected to release updated evidence-based guidelines in 2010. Despite the availability of robust evidence in primary prevention patients, controversies regarding treatment of special patient populations (e.g., women, very elderly) remain.
This educational activity will provide knowledge and expert instruction for pharmacists when recommending therapy for dyslipidemia. Using active learning techniques, current recommendations for treatment guidelines and pharmacotherapy will be discussed, as well as emerging therapies. Clinically relevant controversies regarding the management of dyslipidemia in women and very elderly patients will be presented.
Faculty: Joseph Saseen, Pharm.D., FCCP, FNLA, BCPS, CLS
Continuing Education The program was originally presented at the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada, in December of 2009. Continuing education for this podcast is available until February 28, 2011. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. ACPE activity #204-000-09-439-H01P.
Credits: 1 hour (0.1 CEU) of continuing pharmacy education credit
Summary: The content for these interviews was adapted from interviews with the faculty that were recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
C.E. Credits: Not available for this activity.
Part 1 Best Practices in VTE Prophylaxis
Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA
Professor and Pharmacotherapy Specialist
University of Maryland School of Pharmacy
Baltimore, Maryland
Clinical Specialist
West Palm Beach VA Medical Center
West Palm Beach, Florida
(10 minutes)
Part 2 Questions, Dilemmas and Conundrums that Arise When Managing Patients with Unique Needs Who Are at Risk for VTE
William E. Dager, Pharm.D., BCPS, FCSHP, FCCP, FCCM
Pharmacist Specialist
UC Davis Medical Center
Clinical Professor of Pharmacy
University of California, San Francisco, and Touro School of Pharmacy
Clinical Professor of Medicine
University of California, Davis
Sacramento, California
(21 minutes)
Part 3 New Agents for VTE Prophylaxis
Toby C. Trujillo, Pharm.D., BCPS
Associate Professor
University of Colorado Denver School of Pharmacy
Clinical Specialist – Cardiology/Anticoagulation
Director of Inpatient Anticoagulation – Thrombosis Management Service
University of Colorado Hospital
Aurora, Colorado
(7 minutes)
These interviews are part of a multi-format educational initiative for pharmacists planned and coordinated by ASHP Advantage and supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC. Find complete information at www.ashpadvantage.com/vte.
Summary: The content for these podcasts was adapted from interviews with the faculty that were recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
C.E. Credits: Not available for this activity.
Part 1 Outsourcing the Compounding of Sterile Preparations
Andrew J. Donnelly, Pharm.D., M.B.A., FASHP
Director of Pharmacy Services
University of Illinois Medical Center at Chicago
Clinical Professor of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois
(8 minutes)
Part 2 Writing Requests for Proposals, or RFPs, and Contracts
Karen Bertch, Pharm.D., FCCP
Director, Formulary Development
Premier, Inc.
Charlotte, North Carolina
(6 minutes)
Part 3 Considerations in Outsourcing Anesthesia Services
Tricia A. Meyer, M.S., Pharm.D., FASHP
Director of Pharmacy
Scott and White Healthcare
Assistant Professor of Anesthesiology
Texas A&M University College of Medicine
Adjunct Assistant Professor of Pharmacy Practice
Texas A&M Irma Lerma Rangel College of Pharmacy
Temple, Texas
(5 minutes)
These interviews are part of a multi-format educational initiative for pharmacists planned and coordinated by ASHP Advantage and supported by an educational grant from PharMEDium Services, LLC. Find complete information at www.ashpadvantage.com/outsource.
Summary: The content for these podcasts was adapted from interviews with the faculty that were recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
C.E. Credits: Not available for this activity.
Part 1 FDA Amendments Act of 2007: Implications for Pharmacists and Pharmacies
Justine Coffey, J.D., LL.M.
Director, Federal Regulatory Affairs
Government Affairs Division
American Society of Health-System Pharmacists
Bethesda, Maryland
(7 minutes)
Part 2 Practical Applications, Challenges, and Opportunities in Implementing REMS
JoAnn Stubbings, R.Ph., MCHA
Manager, Research and Public Policy
Ambulatory Care Pharmacy Department
University of Illinois at Chicago College of Pharmacy
Chicago, Illinois (6 minutes)
Part 3 Key Components and Emerging Trends with Respect to REMS
James M. Hoffman, Pharm.D., M.S., BCPS
Medication Outcomes and Safety Officer
St. Jude Children's Research Hospital
Memphis, Tennessee
(6 minutes)
These interviews are part of a multi-format educational initiative for pharmacists planned and coordinated by ASHP Advantage and supported by an educational grant from Roche. Find complete information at www.ashpadvantage.com/fdaaa.
Summary: The content for these podcasts was adapted from interviews with the faculty that were recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
C.E. Credits: Not available for this activity.
Part 1 The Importance of Bone Health and Risk Assessment
Eric J. MacLaughlin, Pharm.D., FCCP, BCPS
Associate Professor and Head of Adult Medicine Division
School of Pharmacy
Texas Tech University Health Sciences Center
Amarillo, Texas
(11:19 minutes)
Part 2 The 'Obvious': Promoting Bone Health in Postmenopausal Women
Sheryl F. Vondracek, Pharm.D., FCCP, BCPS
Associate Professor
Department of Clinical Pharmacy
University of Colorado Denver School of Pharmacy
Aurora, Colorado
(15:30 minutes)
Part 3 The 'Not-So-Obvious': Promoting Bone Health in Patients Receiving Therapy for Breast or Prostate Cancer
Laura Boehnke Michaud, Pharm.D., FASHP, BCOP
Clinical Pharmacy Specialist
Manager, Clinical Pharmacy Services
The University of Texas M. D. Anderson Cancer Center
Houston, Texas
(10:27 minutes)
These interviews are part of a multi-format educational initiative for pharmacists planned and coordinated by ASHP Advantage and supported by an educational donation provided by Amgen. Find complete information at www.ashpadvantage.com/bonehealth
Faculty Interviews from CE in the Mornings 2009 – Recorded live at the 44th ASHP Midyear Clinical Meeting and Exhibition
Summary: The content for this podcast was adapted from an interview that was recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
Faculty: Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Assistant Director of Experiential Education
Assistant Professor
Department of Pharmacy Practice
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Curtis L. Triplitt, Pharm.D., CDE
Clinical Assistant Professor of Medicine, Division of Diabetes
University of Texas Health Science Center at San Antonio
Clinical Specialist
Texas Diabetes Institute
San Antonio, Texas
C.E. Credits: Not available for this activity. Duration: 16:14 minutes
Summary: The content for this podcast was adapted from an interview that was recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
Faculty: Debra A. Goff, Pharm.D., FCCP
Clinical Associate Professor
The Ohio State University College of Pharmacy
Infectious Diseases Specialist
The Ohio State University Medical Center
Columbus, Ohio
C.E. Credits: Not available for this activity. Duration: 12:18 minutes
Summary: The content for this podcast was adapted from an interview that was recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
Faculty: Michael D. Hogue, Pharm.D., FAPhA
Director, Experiential Program
Associate Professor of Pharmacy Practice
McWhorter School of Pharmacy
Samford University
Birmingham, Alabama
C.E. Credits: Not available for this activity. Duration: 11:55 minutes
Summary: The content for this podcast was adapted from an interview that was recorded in December 2009 during the 44th ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, Nevada.
Faculty: Joseph Saseen, Pharm.D., FCCP, FNLA, BCPS, CLS
Professor
University of Colorado Denver
Schools of Pharmacy and Medicine
Aurora, Colorado
C.E. Credits: Not available for this activity. Duration: 17:33 minutes
These interviews are part of a multi-format educational initiative for pharmacists planned and coordinated by ASHP Advantage and supported by an educational grant from Merck. Find complete information at www.ashpadvantage.com/cemornings
Summary: The content for these podcasts was recorded live in November of 2009. It was written and presented by Steven M. Riddle, R.Ph., BCPS, Medication Utilization and Quality Improvement Pharmacist, University of Washington, Harborview Medical Center
C.E. Credits: Not available for this activity. Duration: 16 minutes
This podcast was produced by ASHP Advantage and made possible by the ASHP Quality Improvement Initiative and sanofi-aventis.
Summary: The content for these podcasts was adapted from interviews conducted by David Chen on June 15, 2009, during the ASHP 2009 Summer Meeting and Exhibition.
Part 1 FDA Amendments Act of 2007: Implications for Drug Safety and for Pharmacists
Brian M. Meyer, M.B.A.
Director, Government Affairs Division
American Society of Health-System Pharmacists
Bethesda, Maryland
(4 minutes)
Part 2 Risk Evaluation and Mitigation Strategies: Pros, Cons, and Essential Components
Rita Shane, Pharm.D., FASHP, Program Chair
Director, Pharmacy Services
Cedars-Sinai Medical Center
Los Angeles, California
(9 minutes)
Part 3 Restricted Drug Distribution Systems as a Strategy for Ensuring Drug Safety
Bonnie E. Kirschenbaum, M.S., FASHP, FCSHP
Healthcare Consultant, Columnist
Breckenridge, Colorado
(14 minutes)
Interviews Conducted by:
David Chen, R.Ph., MBA
Director, Pharmacy Practice Sections
Director, Section of Pharmacy Practice Managers
American Society of Health-System Pharmacists®
This podcast series was produced by ASHP Advantage. This activity was supported by an educational donation provided by Amgen.
Summary: The content for these podcasts was adapted from interviews that were recorded at the 43rd ASHP Midyear Clinical Meeting and Exhibition in December 2008.
Part 1 Focus on Quality Indicators.
Kasey Thompson, Pharm.D.
Vice President of the Office of Policy, Planning, and Communication
American Society of Health-System Pharmacists
(12 minutes)
Part 2 Identifying Quality Indicators and Tips for Effectively Working with the Quality Department
Patricia Kienle, R.Ph., MPA, FASHP
Director of Accreditation and Medication Safety for the Pharmacy Services
Cardinal Health
(10 minutes)
Part 3 Does Pay for Performance Impact Your Practice?
Steven M. Riddle, R.Ph., BCPS
Medication Utilization and Quality Improvement Pharmacist
University of Washington
Harborview Medical Center
(14 minutes)
Part 4 Effective Reporting of Quality Performance Metrics
Jannet M. Carmichael, Pharm.D., BCPS, FCCP
VISN 21 Pharmacy Executive
VA Sierra Pacific Network
(13 minutes)
This series of podcasts was produced by ASHP Advantage and made possible by the ASHP Quality Improvement Initiative and sanofi-aventis.
Summary: New responsibilities for pharmacy technicians are being identified throughout the profession of pharmacy, transitioning the position of pharmacy technician from a job to a career. Participants will learn how training and certification are the keys to professional advancement. The use of Certified Pharmacy Technicians can free-up the pharmacist for patient-focused services.
Speakers will highlight the opportunities available for pharmacy technician advancement. A PTCB update including accreditation status and consumer perceptions will also be presented. Evolution and the future of regulation of pharmacy technicians will be reviewed. The session will describe the benefits of creating a career path for technicians with a focus on training, recruitment, and retention.
Part 1 IV Sterile Compounding and Regulatory Affairs: Expanding the Role of Pharmacy Technicians
Presented by Angela Turner Cassano, Pharm.D., BCPS
(32 minutes)
Part 2 Pharmacy Technician Roles inSterile IV Compounding: Challenges, Opportunities, and Competencies
Presented by Barbara Hintzen, BBA, CPhT
(24 minutes)
Part 3 PTCB Certification Matters: Trained, Tested, Trusted
Presented by Melissa Murer Corrigan, R.Ph.
(25 minutes)
Continuing Education The program was originally presented at the 43rd ASHP Midyear Clinical Meeting and Exhibition in Orlando, Florida, in December of 2008. Continuing education for this podcast is available until August 31, 2010, for pharmacists and pharmacy technicians. To be eligible for continuing education credit, you must complete the post-test and activity evaluation online at the ASHP Learning Center. Its ACPE Universal Activity Number is 204-000-09-563-H04P and for pharmacy technicians 204-000-09-563-H04T.
This activity is planned and coordinated by ASHP Advantage. It is supported by an educational grant from the Pharmacy Technician Certification Board (PTCB).
Summary: During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems.
This podcast includes the interview with WIBW in Topeka, Kansas, and the interview with Metro Networks Minneapolis in Minneapolis, Minnesota.
Continuing education credits are not available with this podcast.
Podcast was produced by ASHP Advantage. The radio tour was planned and conducted by the ASHP Research and Education Foundation.
Eleventh Annual ASHP Conference for Leaders in Health-System Pharmacy
Summary: This podcast is based on a program that was originally presented live as part of the 2006 ASHP Conference for Leaders, which was held in Chicago, Illinois, October 16-17, 2006. The theme of the conference was "Developing High Performing Staff and Services."
The presentation was written and presented by Kasey K. Thompson, Pharm.D., who is the Director, Practice Standards and Quality Division and Director, Patient Safety at the American Society of Health-System Pharmacists in Bethesda, Maryland. It was repurposed as a podcast by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
C.E. Credits: Not available for this activity. Duration: 39 minutes
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers. The ASHP Conference for Leaders was made possible by the support of Amgen, Eli Lilly, Roche Pharmaceuticals, and Wyeth.
Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy
Summary: This podcast is based on a program that was originally presented live as part of the Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy. The conference was held October 17 and 18, 2005. The theme of the conference was "Balancing Competing Demands: Practical Strategies for Pharmacy Leaders."
The live program was written and presented by Anne T. Jarrett, Assistant Director of Pharmacy at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina; Rose Marie Babbitt, Associate Director of Pharmacy at Parkland Health and Hospital Systems in Dallas, Texas; and Rita R. Shane, Director of Pharmacy Services at Cedars-Sinai Medical Center in Los Angeles, California.
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
C.E. Credits: Not available for this activity. Duration: 14 minutes
Summary: This podcast is based on a program that was originally presented live as part of the Tenth Annual ASHP Conference for Leaders in Health-System Pharmacy. The conference was held October 17 and 18, 2005. The theme of the conference was "Balancing Competing Demands: Practical Strategies for Pharmacy Leaders."
The live program was written and presented by Mick Hunt, Jr., senior Director of Pharmacy Services at Novation, L.L.C. in Irving, Texas; Daniel Ashby, Director of Pharmacy at Johns Hopkins Hospital in Baltimore, Maryland, and Bruce Scott, Chief Operating Officer at McKesson Medication Management in Brooklyn Park, Minnesota.
C.E. Credits: Not available for this activity. Duration: 17 minutes
This podcast was produced by ASHP Advantage and made possible by the ASHP Section of Pharmacy Practice Managers.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.